Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer

Background: During the last decade, one of the most important treatment options for locally advanced, potencially resectable rectal tumours was neoadjuvant chemoradiotherapy (CRT) followed by surgery.Methods: Effects of the neoadjuvant treatment on surgical outcomes were retrospectively analysed in...

Full description

Bibliographic Details
Main Authors: Attila Paszt, Aurel Ottlakan, Szabolcs Abraham, Zsolt Simonka, Marton Vas, Aniko Maraz, Zoltan Szepes, Laszlo Tiszlavicz, Tibor Nyari, Judit Olah, Gyorgy Lazar
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Pathology and Oncology Research
Subjects:
surgery
chemoradiotherapy
neoadjuvant treatment
capecitabine
advanced rectal cancer
Online Access:https://www.por-journal.com/articles/10.3389/pore.2022.1610722/full

Internet

https://www.por-journal.com/articles/10.3389/pore.2022.1610722/full

Similar Items